Unknown

Dataset Information

0

A small animal model of chronic hepatitis E infection using immunocompromised rats.


ABSTRACT:

Background & aims

HEV variants such as swine genotypes within Paslahepevirus species balayani (HEV-A) and rat HEV (Rocahepevirus ratti; HEV-C1) cause chronic hepatitis E in immunocompromised individuals. There are few reliable and accessible small animal models that accurately reflect chronic HEV infection. We aimed to develop an immunocompromised rat model of chronic hepatitis E infection.

Methods

In this animal model infection study, rats were immunosuppressed with a drug combination (prednisolone, tacrolimus, and mycophenolate mofetil) commonly taken by transplant recipients. Rats were challenged with human- and rat-derived HEV-C1 strains or a human-derived HEV-A strain. Viral load, liver function, liver histology, humoural, and cellular immune responses were monitored.

Results

A high-dose (HD) immunosuppressive regimen consistently prolonged human- and rat-derived HEV-C1 infection in rats (up to 12 weeks post infection) compared with transient infections in low-dose (LD) immunosuppressant-treated and immunocompetent (IC) rats. Mean HEV-C1 viral loads in stool, serum, and liver tissue were higher in HD regimen-treated rats than in LD or IC rats (p <0.05). Alanine aminotransferase elevation was observed in chronically infected rats, which was consistent with histological hepatitis and HEV-C1 antigen expression in liver tissue. None (0/6) of the HD regimen-treated, 5/6 LD regimen-treated, and 6/6 IC rats developed antibodies to HEV-C1 in species-specific immunoblots. Reversal of immunosuppression was associated with clearance of viraemia and restoration of HEV-C1-specific humoural and cellular immune responses in HD regimen-treated rats, mimicking patterns in treated patients with chronic hepatitis E. Viral load suppression was observed with i.p. ribavirin treatment. HD regimen-treated rats remained unsusceptible to HEV-A infection.

Conclusions

We developed a scalable immunosuppressed rat model of chronic hepatitis E that closely mimics this infection phenotype in transplant recipients.

Lay summary

Convenient small animal models are required for the study of chronic hepatitis E in humans. We developed an animal model of chronic hepatitis E by suppressing immune responses of rats with drugs commonly taken by humans as organ transplant rejection prophylaxis. This model closely mimicked features of chronic hepatitis E in humans.

SUBMITTER: Sridhar S 

PROVIDER: S-EPMC9424580 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background & aims</h4>HEV variants such as swine genotypes within <i>Paslahepevirus</i> species <i>balayani</i> (HEV-A) and rat HEV (<i>Rocahepevirus ratti</i>; HEV-C1) cause chronic hepatitis E in immunocompromised individuals. There are few reliable and accessible small animal models that accurately reflect chronic HEV infection. We aimed to develop an immunocompromised rat model of chronic hepatitis E infection.<h4>Methods</h4>In this animal model infection study, rats were immunosuppress  ...[more]

Similar Datasets

| S-EPMC2775186 | biostudies-other
| PRJEB48702 | ENA
| S-EPMC89864 | biostudies-literature
| S-EPMC7308725 | biostudies-literature
| S-EPMC8708279 | biostudies-literature
2019-09-25 | GSE137911 | GEO
| S-EPMC3521758 | biostudies-literature
| S-EPMC7197424 | biostudies-literature
| S-EPMC10948336 | biostudies-literature
| S-EPMC3835983 | biostudies-literature